Will the next biotech breakthrough be digital before it’s biological with Bibi Ephraim

Episode notes

AI is transforming biotechnology from the inside out. What was once a world of petri dishes and pipettes is now increasingly powered by algorithms, models, and digital twins. But as machine learning accelerates drug discovery and reshapes clinical trials, how far can we go before biology itself becomes the follower, not the leader? In this episode of Tech Tomorrow , David Elliman speaks with Bibi Ephraim, Head of Digital Sciences at Genentech, about how artificial intelligence is redefining the biotech landscape. They explore how data-driven approaches are rapidly compressing timelines in drug discovery, enabling precision medicine, and even simulating virtual clinical trials. They also tackle the cultural and organisational transformations needed to make digital biotech work; from breaking down data silos and fostering collaboration across competitors, to treating data as a product and investing in strong governance. Drawing parallels with digital transformation in other industries, they ask what it will take for biotech to move from project-based to product-based innovation, and why pre-competitive collaboration could unlock the next generation of cures.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Can responsible AI beat hallucinations?The ITPro Podcast · on Agentic AI95 / 100
• Why your research needs a “thinking cave” with Sarah KlingThe Curiosity Current: A Market Research Podcast · on Agentic AI89 / 100
• AI Didn't Change the Rules, It Raised the Stakes (ep.13)Practical Cybersecurity with Jen Stone · on Agentic AI85 / 100
• Who Owns What Your AI Does?The Pre-Read · on Agentic AI85 / 100
• REBOOT: The Trust Advantage: How OpenText is Securing Canada’s Information LayerDisruptors · on Agentic AI82 / 100
• When Cybersecurity Becomes a Safety Issue: Protecting Autonomous and Critical SystemsExploited: The Cyber Truth · on Cyber Resilience Act81 / 100

• Are leaders deploying AI faster than they can effectively govern it with Zahra Shah62 / 100
• Is it possible for tech for good to exist within a for-profit model with Jim Fruchterman86 / 100
• Can executives balance AI innovation with societal responsibility with Lord Clement-Jones80 / 100
• Will AI and digital twins make animal testing in drug discovery obsolete with Professor Julie Frearson85 / 100
• Is irrational AI making our decision-making worse with Stephanie Antonian